|Day Low/High||148.02 / 150.75|
|52 Wk Low/High||135.07 / 179.07|
Upcoming earnings? Optimistic spin on trade? Tech rally? Jim Cramer's got the game plan for next week and he tells investors to keep their cool.
The markets strongly rebounded this week as a few of the major averages pushed into positive year-to-date territory.
If there is a rally, look for a dramatic and very fast sentiment change.
Bearish signals on the charts point to lower prices in the weeks ahead.
We consider ITW a broken stock, not a broken company, and the action in the shares Friday is constructive.
Jim discusses Amazon's monster quarter, Microsoft's strong result, and the plan for Illinois Tool Works and 3M.
Jim Cramer focuses on Walgreens Boots Alliance, Arena Pharmaceutical, Dominion Energy, Tower Semiconductor, Idexx, LexinFintech Holdings and more.
Nick Akins, chairman, president and CEO of American Electric Power, tells Jim Cramer about the company's wind farm project in Oklahoma.
Jim Cramer talks about how tariffs caused a whiplash at Whirlpool.
Domino's Pizza execs tell Jim Cramer how innovation leads to growth.
It's not all about the bond market, says Jim Cramer. The central issues here are trade, tariffs and most important, the stocks themselves, like Facebook and Amazon.
The Glenview, Ill.-based industrial product manufacturer reported earnings of $1.90 per share on revenue of $3.7 billion.
We are encouraged that management maintained its full year organic sales guide and increased earnings per share expectations.
We believe the headline readings to indicate that the US economic expansion remains intact.
We want to quickly jump on this opportunity to rebuild our position.
KLA-Tencor, Microsoft and Intel all report earnings after the close Thursday.
Sales into strength leave us with money to put to work during earnings season.
Jim Cramer focuses on Dropbox, Qualcomm, Skechers USA, Spotify, Nucor, Kratos Defense & Security, American Water Works.
How do you get a stock moving? Jim Cramer says the answer is to invest in technology.
Dan Browne, co-founder, president and CEO of Revance Therapeutics, tells Jim Cramer his company is developing an alternative to Botox.
Gary Wojtaszek, president and CEO of CyrusOne, tells Jim Cramer about the $442 million acquisition of Zenium.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.